SARS-CoV-2 sample pooling

Sample pooling for SARS-CoV-2 testing

Interested in sample pooling?

Interested in sample pooling?

Take a look on this interesting publication about efficient pooling for SARS-CoV-2 testing. The researchers have prepared 94 pools of 10 samples (a total of 940 nasopharyngeal swab samples) which were previously tested for SARS-CoV-2 and assigned them with random numbers. Then, they have used the pools for automated viral RNA purification and subsequent RT-PCR analysis to identify positive pools.

SARS-CoV-2 variant detection

Variant identification

New solutions for SARS-CoV-2 variant identification

New solutions for SARS-CoV-2 variant detection

The observation of variants makes it necessary to take a deeper look on positive SARS-CoV-2 detection results. PerkinElmer has now developed two new solutions to identify variants of SARS-CoV-2.

The PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay is based on real-time RT-PCR multiplexing technology and enables the identification of known variants from positive samples (B1.1.7, B.1.351, P.1).

The NEXTFLEX® Variant Seq™ SARS-CoV-2 Kit for Illumina® sequencing enables the identification of existing and new variants of the SARS-CoV-2.

For research use only. Not for use in diagnostic procedures.

chemagic 360 instrument in HIV research

chemagic 360 instrument for HIV research

chemagic™ 360 instrument for HIV studies

chemagic™ 360 instrument in HIV research

Take a look on this interesting publication and learn how the chemagic 360 instrument can help to study the human immunodeficiency virus. In this case the reduction of the HIV-1 integrase efficiency was determined in patients showing drug resistance mutations in reverse transcriptase.

New video – Meet the chemagic team

Meet the chemagic team

Meet the chemagic team

Meet the chemagic™ people

Take a look behind the scenes and meet the people who are responsible for the PerkinElmer chemagen solutions for automated DNA and RNA isolation. Enjoy our new video showing the technical workshops, the manufacturing in Baesweiler, Turku, and Groningen and the amazing people of the chemagic™ products!

New video of explorer™ G3 workstations

chemagic 360 instrument in explorer workstations

explorer™ G3 workstations

New video of explorer™ G3 integrated workstations

Check out this new video about the explorer™ G3 integrated workstations! It shows how these workstations can simplify your daily lab work. Our chemagic™ 360 instruments can be integrated for the automated purification of nucleic acids. Furthermore, it can simplify the microplate handling, liquid handling, and detection.

chemagic cfDNA kits for cancer research

chemagic cfDNA kits for cancer research

Publication for cancer research

chemagic™ cfDNA kits for cancer research

Did you recognized this interesting publication? Please take a look and learn how the efficient extraction of cfDNA with the chemagic cfDNA 5k Kit can help to study primary lung cancer.

Prime Time in our workshops

chemagic Prime instruments

chemagic Prime instruments

Prime Time!

Today is Prime time in our chemagic™ workshops! Our technical team completes these chemagic™ Prime instruments with best care and attention to send them to our customers as soon as possible.

Daily heroes

Daily heroes

Meet our daily heroes

Check out one of our daily heroes!

As development engineer, Andreas answers all your technical questions about our chemagic™ instruments for SARS-CoV-2 related applications and even for all other applications.

Support during pandemic

Support during pandemic

Support during the pandemic!

Support during the pandemic!

Take a look on our colleague Jens who performs an online training with our chemagic Prepito® instrument to support a customer even in in this challenging environment without travelling.

The new variants of SARS-CoV-2

UK variant of SARS-CoV-2

Mutations of SARS-CoV-2

The new variants of SARS-CoV-2

In December 2020 new SARS-CoV-2 variants were detected in the United Kingdom and South Africa. The UK SARS-CoV-2 variant is called B.1.17 (VUI 202012/01), the South African Variant is called B.1.351 and both are characterized by multiple mutations in the spike protein of the SARS-CoV-2 virus. The mutations in the spike protein of the variant leads to false negative results when using RT-PCR assays targeting the S-gene. All PerkinElmer SARS-CoV-2 RT-PCR assays are designed to identify SARS-CoV-2 ORF1ab and N genes, therefore the B.1.1.7 and B.1.351 variants do not affect the detection of SARS-CoV-2 by PerkinElmer RT-PCR assays.